Bruker (BRKR) vs Waters (WAT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Bruker (BRKR) has outperformed Waters (WAT) over the past year, gaining 19.4% versus a gain of 11.8%. Over five years, WAT leads with a +30.1% price change compared with -32.2% for BRKR. Waters is the larger company by market cap ($86.56 billion vs $8.62 billion), about 10.0 times the size.
On valuation, Bruker trades at a lower forward P/E (23.3x vs 26.6x for Waters). Bruker pays a dividend yielding 0.09%, while Waters does not currently pay one. Waters converts more of its revenue into profit, with a net margin of 20.3% versus -0.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRKR | WAT |
|---|---|---|
| Share price | $56.46 | $440.45 |
| Market cap | $8.62B | $86.56B |
| 1-day change | -9.08% | -3.51% |
| YTD return | +19.85% | +15.96% |
| 1-year return | +19.44% | +11.79% |
| 5-year return | -32.16% | +30.15% |
| P/E ratio (TTM) | — | 184.29 |
| Forward P/E | 23.25 | 26.65 |
| EPS (TTM) | $-1.10 | $2.39 |
| Dividend yield | 0.09% | 0.00% |
| Annual dividend | $0.05 | $0.00 |
| Revenue (latest FY) | $3.44B | $3.17B |
| Revenue growth (YoY) | +2.08% | +6.99% |
| Net income (latest FY) | $-8.60M | $642.63M |
| Gross margin | 45.91% | 59.28% |
| Operating margin | 1.98% | 25.36% |
| Net margin | -0.25% | 20.30% |
| 52-week high | $68.98 | $483.33 |
| 52-week low | $32.37 | $282.77 |
| Distance from 52-week high | -18.15% | -8.87% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +20.44% | +14.27% |
| Average volume | 2.32M | 826.62K |
| Shares outstanding | 152.72M | 98.29M |
| Employees | 11,085 | 15,000 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Waters is about 10.0 times larger than Bruker by market value ($86.56B vs $8.62B).
- Waters is more profitable, keeping 20.3 cents of every revenue dollar as net income versus -0.3 cents for Bruker.
About Bruker
BRKR stock →Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,085 employees
About Waters
WAT stock →Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA.
Industrials · Biotechnology: Laboratory Analytical Instruments · 15,000 employees
BRKR vs WAT FAQ
Which is bigger, Bruker or Waters?
Waters (WAT) is larger, with a market capitalization of $86.56B compared with $8.62B for Bruker (BRKR).
Which stock has performed better over the past year, BRKR or WAT?
BRKR returned +19.44% over the past 12 months, compared with +11.79% for WAT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Bruker or Waters?
Bruker pays a dividend yielding 0.09%, while Waters does not currently pay a regular dividend.
Are Bruker and Waters in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.